STELLA, GIULIA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.759
AS - Asia 2.385
EU - Europa 1.631
SA - Sud America 512
AF - Africa 159
OC - Oceania 4
Totale 7.450
Nazione #
US - Stati Uniti d'America 2.645
SG - Singapore 705
CN - Cina 626
VN - Vietnam 401
BR - Brasile 387
IT - Italia 330
HK - Hong Kong 315
RU - Federazione Russa 288
DE - Germania 203
IE - Irlanda 198
FR - Francia 154
FI - Finlandia 146
ZA - Sudafrica 114
GB - Regno Unito 95
IN - India 95
CA - Canada 60
AR - Argentina 51
BD - Bangladesh 50
NL - Olanda 42
MX - Messico 35
SE - Svezia 30
AT - Austria 28
IQ - Iraq 28
JP - Giappone 24
CO - Colombia 20
PL - Polonia 20
CZ - Repubblica Ceca 19
ES - Italia 19
EC - Ecuador 18
TR - Turchia 18
PK - Pakistan 16
ID - Indonesia 14
MA - Marocco 14
PH - Filippine 13
LT - Lituania 12
UA - Ucraina 11
VE - Venezuela 11
SA - Arabia Saudita 10
CL - Cile 9
AZ - Azerbaigian 8
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
KE - Kenya 6
BE - Belgio 5
JM - Giamaica 5
UZ - Uzbekistan 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
KG - Kirghizistan 4
NP - Nepal 4
TH - Thailandia 4
AU - Australia 3
BO - Bolivia 3
IR - Iran 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
AL - Albania 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TJ - Tagikistan 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
Totale 7.441
Città #
San Jose 429
Singapore 379
Ashburn 301
Hong Kong 297
Dallas 286
Beijing 215
Dublin 198
Chandler 147
Ho Chi Minh City 145
Council Bluffs 118
Los Angeles 105
Johannesburg 101
Munich 98
Lauterbourg 97
New York 96
Hanoi 89
Milan 87
Boardman 78
Turku 74
Helsinki 68
Redondo Beach 56
Moscow 47
São Paulo 44
Shanghai 42
Montreal 30
Santa Clara 30
Buffalo 29
Pavia 29
Orem 27
Atlanta 26
Chicago 26
Da Nang 26
Falkenstein 26
Stockholm 24
Chennai 23
Tokyo 23
Nuremberg 21
Denver 20
Princeton 20
Wilmington 20
Brooklyn 19
Frankfurt am Main 19
Lawrence 19
London 18
Medford 17
Phoenix 17
Turin 17
Warsaw 17
Mexico City 16
Seattle 15
Paris 14
Brno 13
Columbus 13
Haiphong 13
Poplar 13
Rio de Janeiro 13
Vienna 13
Biên Hòa 12
Boston 12
Düsseldorf 12
Florence 12
Houston 12
Hyderabad 12
Jacksonville 12
Manchester 12
Nanjing 12
The Dalles 12
Guangzhou 10
San Francisco 10
Shenyang 10
Amsterdam 9
Ankara 9
Baghdad 9
Changsha 9
Rome 9
Toronto 9
Bắc Ninh 8
Curitiba 8
Elk Grove Village 8
Nanchang 8
Querétaro 8
Rubiera 8
Baku 7
Belo Horizonte 7
Brasília 7
Buenos Aires 7
Guayaquil 7
Porto Alegre 7
Pune 7
Saluzzo 7
Washington 7
Cape Town 6
Mumbai 6
New Delhi 6
Ninh Bình 6
Olomouc 6
Secaucus 6
Tianjin 6
Zhengzhou 6
Amman 5
Totale 4.631
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 133
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 130
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 129
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 128
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 125
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 120
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 119
From interconnection between genes and microenvironment to novel immunotherapeutic approaches in upper gastro-intestinal cancers—A multidisciplinary perspective 110
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 109
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 107
Case Report: All That Glisters Is Not* Cancer 107
CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency 106
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 102
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 101
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 100
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 98
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 98
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 98
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 98
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Unexpected responses to EGFR inhibition in NSCLC 95
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 95
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 93
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 93
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 91
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective 90
A 28-Year-Old Man with Stridor and Dyspnea 89
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 88
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 88
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives 87
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms 87
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study 86
Bayesian Networks in the Management of Hospital Admissions: A Comparison between Explainable AI and Black Box AI during the Pandemic † 83
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 83
Phenotyping sarcoidosis: a single institution retrospective analysis 82
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 79
Phenotypes and Serum Biomarkers in Sarcoidosis 78
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer 77
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction 76
COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining 75
A Rare Case of Exophiala Dermatitidis Isolation in a Patient with Non-Cystic Fibrosis Bronchiectasis: Colonization or True Infection? 75
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design 74
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis 73
Asbestos and Mesothelioma 72
Predictive markers associated to fibrotic evolution in hypersensitivity pneumonitis: a single institution's analysis 70
Radiomics features as predictive and prognostic biomarkers in NSCLC 70
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review 69
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 69
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 68
Pulmonary Infiltrates in a Non-Cystic Fibrosis Bronchiectasis Patient: A Case Report 66
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 66
Radiomics features as predictive and prognostic biomarkers in NSCLC 66
Adaptations in maximal oxygen consumption and lower-limb muscle oxygen extraction capacity following 4 months of moderate-intensity training in Parkinson's disease: a pilot study 65
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 65
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 65
Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience 65
MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin 64
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 63
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab 63
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study 62
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 62
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? 61
RON tyrosine kinase mutations in brain metastases from lung cancer 61
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease 61
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 61
Management of severe pneumonia in respiratory non-intensive care unit: a retrospective study from a single center experience 58
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review 57
Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study 56
A case report of primary signet ring cell carcinoma of the lung: Imaging study and literature review 56
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma 55
Phenotyping Bronchiectasis Frequent Exacerbator: A Single Centre Retrospective Cluster Analysis 54
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 54
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 51
From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune–Inflammatory Landscape Underlying Lung Cancer Distant Spreading—A Narrative Review 51
Cancers of unknown primary origin: Current perspectives and future therapeutic strategies 50
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination 49
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery 47
Evolving concepts in COPDand lung cancer: a narrative review 46
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma 45
Lung disease recalling paraseptal emphysema in a patient with Goltz syndrome 44
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis 44
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes 43
Caveolin-1 as a promoter of tumour spreading: When, how, where and why 43
Carbon nanotubes and pleural damage: Perspectives of nanosafety in the light of asbestos experience 42
Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study 40
Lung-Seeking Metastases 40
Telomeropathies: an emerging spectrum of disorders with important implications for patients with interstitial lung disease 38
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 38
Non-neuronal cholinergic system in airways and lung cancer susceptibility 38
The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis 38
Lung tumors, COPD and immune response: is epigenetics the bottom line? 37
Sex and gender differences during the lung lifespan: unveiling a pivotal impact 34
Lymph-node mapping in lung cancer staging: accuracy and limits of the current approaches 32
Reply to Althuwaybi et al 28
Surgical options to early-stage lung cancer: can "the less" mean "the safe"? 27
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study) 27
Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients 27
New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma 27
Totale 7.323
Categoria #
all - tutte 31.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022104 19 0 0 2 1 6 0 7 7 4 12 46
2022/2023476 39 37 1 51 37 33 0 23 222 2 26 5
2023/2024404 44 55 19 23 52 85 32 21 5 12 9 47
2024/20251.693 40 43 30 64 40 173 98 104 398 114 199 390
2025/20264.794 304 425 426 717 599 181 707 258 475 373 193 136
Totale 7.600